Evidence map›Paper›PMID 37311034›Full record

ArticleScience signaling2023

Modulation of the substrate specificity of the kinase PDK1 by distinct conformations of the full-length protein.

Mariana Sacerdoti, Lissy Z F Gross, Andrew M Riley, Karin Zehnder, Abhijeet Ghode, Sebastián Klinke, Ganesh Srinivasan Anand, Kristina Paris, Angelika Winkel, Amanda K Herbrand and 14 more

Open access · hybridAbstract read
In one paragraph

Article in Science signaling, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. PI3 K/AKT/mTOR pathway and its role in breast cancer stem cells.Naunyn-Schmiedeberg's archives of pharmacology · 2025
    Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Post-translational modifications in prion diseases.Frontiers in molecular neuroscience · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 10 institutions in 5 countries.

Mariana SacerdotiInstituto de Investigación en Biomedicina de Buenos Aires (IBioBA)-CONICET-Partner Institute of the Max Planck Society, Buenos Aires C1425FQD, Argentina.ORCID 0000-0001-6682-6719
Lissy Z F GrossInstituto de Investigación en Biomedicina de Buenos Aires (IBioBA)-CONICET-Partner Institute of the Max Planck Society, Buenos Aires C1425FQD, Argentina.ORCID 0000-0001-6182-0086
Andrew M RileyMedicinal Chemistry and Drug Discovery, Department of Pharmacology, University of Oxford, Mansfield Road, Oxford OX1 3QT, UK.ORCID 0000-0001-9003-3540
Karin ZehnderDepartment of Internal Medicine I, Universitätsklinikum Frankfurt, Theodor-Stern-Kai 7, 60590 Frankfurt, Germany.
Abhijeet GhodeBiological Sciences, National University of Singapore, Singapore 119077, Singapore.ORCID 0000-0002-8619-703X
Sebastián KlinkeFundación Instituto Leloir, IIBBA-CONICET, and Plataforma Argentina de Biología Estructural y Metabolómica PLABEM, Buenos Aires C1405BWE, Argentina.ORCID 0000-0002-8777-0870
Ganesh Srinivasan AnandBiological Sciences, National University of Singapore, Singapore 119077, Singapore.ORCID 0000-0001-8995-3067
Kristina ParisDepartment of Computational and Systems Biology, University of Pittsburgh, Pittsburgh, PA 15260, USA.ORCID 0000-0003-2884-6166
Angelika WinkelDepartment of Internal Medicine I, Universitätsklinikum Frankfurt, Theodor-Stern-Kai 7, 60590 Frankfurt, Germany.
Amanda K HerbrandDepartment of Internal Medicine I, Universitätsklinikum Frankfurt, Theodor-Stern-Kai 7, 60590 Frankfurt, Germany.ORCID 0000-0002-4345-8199
H Yasmin GodageWolfson Laboratory of Medicinal Chemistry, Department of Life Sciences, University of Bath, Claverton Down, Bath BA2 7AY, UK.
Gyles E CozierWolfson Laboratory of Medicinal Chemistry, Department of Life Sciences, University of Bath, Claverton Down, Bath BA2 7AY, UK.ORCID 0000-0003-2851-0902
Evelyn SüßDepartment of Internal Medicine I, Universitätsklinikum Frankfurt, Theodor-Stern-Kai 7, 60590 Frankfurt, Germany.
Jörg O SchulzeDepartment of Internal Medicine I, Universitätsklinikum Frankfurt, Theodor-Stern-Kai 7, 60590 Frankfurt, Germany.
Daniel Pastor-FloresDepartment of Internal Medicine I, Universitätsklinikum Frankfurt, Theodor-Stern-Kai 7, 60590 Frankfurt, Germany.
Mariela BolliniCentro de Investigaciones en Bionanociencias 'Elizabeth Jares-Erijman' CIBION, CONICET, Buenos Aires C1425FQD, Argentina.
María Victoria CappellariCentro de Investigaciones en Bionanociencias 'Elizabeth Jares-Erijman' CIBION, CONICET, Buenos Aires C1425FQD, Argentina.ORCID 0000-0001-9804-6389
Dmitri SvergunEuropean Molecular Biology Laboratory (EMBL), Hamburg Unit, 22607 Hamburg, Germany.ORCID 0000-0003-0830-5696
Melissa A GräwertEuropean Molecular Biology Laboratory (EMBL), Hamburg Unit, 22607 Hamburg, Germany.ORCID 0000-0001-7547-636X
Pedro F AramendiaCentro de Investigaciones en Bionanociencias 'Elizabeth Jares-Erijman' CIBION, CONICET, Buenos Aires C1425FQD, Argentina.
Alejandro E LerouxInstituto de Investigación en Biomedicina de Buenos Aires (IBioBA)-CONICET-Partner Institute of the Max Planck Society, Buenos Aires C1425FQD, Argentina.ORCID 0000-0001-6149-3572
Barry V L PotterMedicinal Chemistry and Drug Discovery, Department of Pharmacology, University of Oxford, Mansfield Road, Oxford OX1 3QT, UK.ORCID 0000-0003-3255-9135
Carlos J CamachoDepartment of Computational and Systems Biology, University of Pittsburgh, Pittsburgh, PA 15260, USA.ORCID 0000-0003-1741-8529
Ricardo M BiondiInstituto de Investigación en Biomedicina de Buenos Aires (IBioBA)-CONICET-Partner Institute of the Max Planck Society, Buenos Aires C1425FQD, Argentina.ORCID 0000-0002-8873-7167
Goethe University Frankfurt · DEBiomedicine Research Institute of Buenos Aires - CONICET - Partner Institute of the Max Planck Society · ARConsejo Nacional de Investigaciones Científicas y Técnicas · AREuropean Molecular Biology Laboratory · DEUniversity of Bath · GBUniversity of Oxford · GBUniversity of Pittsburgh · USFundación Instituto Leloir · ARNational University of Singapore · SGPennsylvania State University · US

Funding

Wellcome Trust 101010
6 · The paper itself

Abstract

The activation of at least 23 different mammalian kinases requires the phosphorylation of their hydrophobic motifs by the kinase PDK1. A linker connects the phosphoinositide-binding PH domain to the catalytic domain, which contains a docking site for substrates called the PIF pocket. Here, we used a chemical biology approach to show that PDK1 existed in equilibrium between at least three distinct conformations with differing substrate specificities. The inositol polyphosphate derivative HYG8 bound to the PH domain and disrupted PDK1 dimerization by stabilizing a monomeric conformation in which the PH domain associated with the catalytic domain and the PIF pocket was accessible. In the absence of lipids, HYG8 potently inhibited the phosphorylation of Akt (also termed PKB) but did not affect the intrinsic activity of PDK1 or the phosphorylation of SGK, which requires docking to the PIF pocket. In contrast, the small-molecule valsartan bound to the PIF pocket and stabilized a second distinct monomeric conformation. Our study reveals dynamic conformations of full-length PDK1 in which the location of the linker and the PH domain relative to the catalytic domain determines the selective phosphorylation of PDK1 substrates. The study further suggests new approaches for the design of drugs to selectively modulate signaling downstream of PDK1.

Indexed as

MammalsPolyphosphatesAnimalsCatalytic DomainDimerizationPhosphorylationSubstrate SpecificityPolyphosphates

Identifiers

PMID37311034
PMCPMC7614687
OpenAlexW4380449933

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.